JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.104, sa.7, ss.2527-2534, 2019 (SCI İndekslerine Giren Dergi)
Context: Dopamine agonist (DA)-induced impulse control disorder (ICD) in patients with prolactinomas is not sufficiently known.